|
1
|
Munn DH, Sharma MD, Baban B, Harding HP,
Zhang Y, Ron D and Mellor AL: GCN2 kinase in T cells mediates
proliferative arrest and anergy induction in response to
indoleamine 2,3-dioxygenase. Immunity. 22:633–642. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eleftheriadis T, Pissas G, Yiannaki E,
Markala D, Arampatzis S, Antoniadi G, Liakopoulos V and Stefanidis
I: Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte
reaction affects glucose influx and enzymes involved in aerobic
glycolysis and glutaminolysis in alloreactive T-cells. Hum Immunol.
74:1501–1509. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eleftheriadis T, Pissas G, Antoniadi G,
Spanoulis A, Liakopoulos V and Stefanidis I: Indoleamine
2,3-dioxygenase increases p53 levels in alloreactive human T cells,
and both indoleamine 2,3-dioxygenase and p53 suppress glucose
uptake, glycolysis and proliferation. Int Immunol. 26:673–684.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eleftheriadis T, Pissas G, Antoniadi G,
Liakopoulos V and Stefanidis I: Indoleamine 2,3-dioxygenase
depletes tryptophan, activates general control non-derepressible 2
kinase and down-regulates key enzymes involved in fatty acid
synthesis in primary human CD4+ T cells. Immunology.
146:292–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cobbold SP, Adams E, Farquhar CA, Nolan
KF, Howie D, Lui KO, Fairchild PJ, Mellor AL, Ron D and Waldmann H:
Infectious tolerance via the consumption of essential amino acids
and mTOR signaling. Proc Natl Acad Sci USA. 106:12055–12060. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mezrich JD, Fechner JH, Zhang X, Johnson
BP, Burlingham WJ and Bradfield CA: An interaction between
kynurenine and the aryl hydrocarbon receptor can generate
regulatory T cells. J Immunol. 185:3190–3198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eleftheriadis T, Pissas G, Sounidaki M,
Tsogka K, Antoniadis N, Antoniadi G, Liakopoulos V and Stefanidis
I: Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances
carnitine palmitoyltransferase I activity and fatty acid oxidation,
and exerts fatty acid-dependent effects in human alloreactive
CD4x T-cells. Int J Mol Med. 38:1605–1613. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Curti A, Trabanelli S, Salvestrini V,
Baccarani M and Lemoli RM: The role of indoleamine 2,3-dioxygenase
in the induction of immune tolerance: Focus on hematology. Blood.
113:2394–2401. 2009. View Article : Google Scholar
|
|
9
|
Wang R, Dillon CP, Shi LZ, Milasta S,
Carter R, Finkelstein D, McCormick LL, Fitzgerald P, Chi H, Munger
J and Green DR: The transcription factor Myc controls metabolic
reprogramming upon T lymphocyte activation. Immunity. 35:871–882.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caro-Maldonado A, Gerriets VA and Rathmell
JC: Matched and mismatched metabolic fuels in lymphocyte function.
Semin Immunol. 24:405–413. 2012. View Article : Google Scholar
|
|
11
|
Macintyre AN, Gerriets VA, Nichols AG,
Michalek RD, Rudolph MC, Deoliveira D, Anderson SM, Abel ED, Chen
BJ, Hale LP and Rathmell JC: The glucose transporter Glut1 is
selectively essential for CD4 T cell activation and effector
function. Cell Metab. 20:61–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Michalek RD, Gerriets VA, Jacobs SR,
Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG and
Rathmell JC: Cutting edge: Distinct glycolytic and lipid oxidative
metabolic programs are essential for effector and regulatory
CD4+ T cell subsets. J Immunol. 186:3299–3303. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Eleftheriadis T, Pissas G, Antoniadi G,
Tsogca K, Sounidaki M, Liakopoulos V and Stefanidis I: Indoleamine
2,3-dioxygenase downregulates T-cell receptor complex ζ-chain and
c-Myc, and reduces proliferation, lactate dehydrogenase levels and
mitochondrial glutaminase in human T-cells. Mol Med Rep.
13:925–932. 2015. View Article : Google Scholar
|
|
14
|
Gurtner GJ, Newberry RD, Schloemann SR,
McDonald KG and Stenson WF: Inhibition of indoleamine
2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in
mice. Gastroenterology. 125:1762–1773. 2003. View Article : Google Scholar
|
|
15
|
Kwidzinski E, Bunse J, Aktas O, Richter D,
Mutlu L, Zipp F, Nitsch R and Bechmann I: Indolamine
2,3-dioxygenase is expressed in the CNS and down-regulates
autoimmune inflammation. FASEB J. 19:1347–1349. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alexander AM, Crawford M, Bertera S,
Rudert WA, Takikawa O, Robbins PD and Trucco M: Indoleamine
2,3-dioxygenase expression in transplanted NOD Islets prolongs
graft survival after adoptive transfer of diabetogenic splenocytes.
Diabetes. 51:356–365. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Tredget EE, Ghaffari A, Lin X,
Kilani RT and Ghahary A: Local expression of indoleamine
2,3-dioxygenase protects engraftment of xenogeneic skin substitute.
J Invest Dermatol. 126:128–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Munn DH, Zhou M, Attwood JT, Bondarev I,
Conway SJ, Marshall B, Brown C and Mellor AL: Prevention of
allogeneic fetal rejection by tryptophan catabolism. Science.
281:1191–1193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Munn DH and Mellor AL: Indoleamine
2,3-dioxygenase and tumor-induced tolerance. J Clin Invest.
117:1147–1154. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sato T, Deiwick A, Raddatz G, Koyama K and
Schlitt HJ: Interactions of allogeneic human mononuclear cells in
the two-way mixed leucocyte culture (MLC): Influence of cell
numbers, subpopulations and cyclosporin. Clin Exp Immunol.
115:301–308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Staiger K, Staiger H, Weigert C, Haas C,
Häring HU and Kellerer M: Saturated, but not unsaturated, fatty
acids induce apoptosis of human coronary artery endothelial cells
via nuclear factor-kappaB activation. Diabetes. 55:3121–3126. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fadeel B and Orrenius S: Apoptosis: A
basic biological phenomenon with wide-ranging implications in human
disease. J Intern Med. 258:479–517. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castilho BA, Shanmugam R, Silva RC, Ramesh
R, Himme BM and Sattlegger E: Keeping the eIF2 alpha kinase Gcn2 in
check. Biochim Biophys Acta. 1843:1948–1968. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma XM and Blenis J: Molecular mechanisms
of mTOR-mediated translational control. Nat Rev Mol Cell Biol.
10:307–318. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gallinetti J, Harputlugil E and Mitchell
JR: Amino acid sensing in dietary-restriction-mediated longevity:
Roles of signal-transducing kinases GCN2 and TOR. Biochem J.
449:1–10. 2013. View Article : Google Scholar :
|
|
26
|
Ma Q: Induction of CYP1A1. The AhR/DRE
paradigm: Transcription, receptor regulation, and expanding
biological roles. Curr Drug Metab. 2:149–164. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lopaschuk GD, Ussher JR, Folmes CD, Jaswal
JS and Stanley WC: Myocardial fatty acid metabolism in health and
disease. Physiol Rev. 90:207–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schreurs M, Kuipers F and van der Leij FR:
Regulatory enzymes of mitochondrial beta-oxidation as targets for
treatment of the metabolic syndrome. Obes Rev. 11:380–388. 2010.
View Article : Google Scholar
|
|
30
|
Wang C, Xu CX, Krager SL, Bottum KM, Liao
DF and Tischkau SA: Aryl hydrocarbon receptor deficiency enhances
insulin sensitivity and reduces PPAR-α pathway activity in mice.
Environ Health Perspect. 119:1739–1744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song S, Attia RR, Connaughton S, Niesen
MI, Ness GC, Elam MB, Hori RT, Cook GA and Park EA: Peroxisome
proliferator activated receptor alpha (PPARalpha) and PPAR gamma
coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA
(CPT-1A) via independent gene elements. Mol Cell Endocrinol.
325:54–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kok BP, Dyck JR, Harris TE and Brindley
DN: Differential regulation of the expressions of the PGC-1α splice
variants, lipins, and PPARα in heart compared to liver. J Lipid
Res. 54:1662–1677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen Y, Wang Y, Huang Y, Zeng H, Hu B,
Guan L, Zhang H, Yu AM, Johnson CH, Gonzalez FJ, et al: PPARα
regulates tumor cell proliferation and senescence via a novel
target gene carnitine palmitoyltransferase 1C. Carcinogenesis.
38:474–483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dunn SE, Ousman SS, Sobel RA, Zuniga L,
Baranzini SE, Youssef S, Crowell A, Loh J, Oksenberg J and Steinman
L: Peroxisome proliferator-activated receptor (PPAR)alpha
expression in T cells mediates gender differences in development of
T cell-mediated autoimmunity. J Exp Med. 204:321–330. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee JW, Bajwa PJ, Carson MJ, Jeske DR,
Cong Y, Elson CO, Lytle C and Straus DS: Fenofibrate represses
interleukin-17 and interferon-gamma expression and improves colitis
in interleukin-10-deficient mice. Gastroenterology. 133:108–123.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gocke AR, Hussain RZ, Yang Y, Peng H,
Weiner J, Ben LH, Drew PD, Stuve O, Lovett-Racke AE and Racke MK:
Transcriptional modulation of the immune response by peroxisome
proliferator-activated receptor-{alpha} agonists in autoimmune
disease. J Immunol. 182:4479–4487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Azuma YT, Nishiyama K, Matsuo Y, Kuwamura
M, Morioka A, Nakajima H and Takeuchi T: PPARα contributes to
colonic protection in mice with DSS-induced colitis. Int
Immunopharmacol. 10:1261–1267. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim MS, Pyun HB and Hwang JK: Panduratin
A, an activator of PPAR-α/δ, suppresses the development of
oxazolone-induced atopic dermatitis-like symptoms in hairless mice.
Life Sci. 100:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lei J, Hasegawa H, Matsumoto T and
Yasukawa M: Peroxisome proliferator-activated receptor α and γ
agonists together with TGF-β convert human
CD4+CD25− T cells into functional Foxp3+
regulatory T cells. J Immunol. 185:7186–7198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hichami A, Yessoufou A, Ghiringhelli F,
Salvadori F, Moutairou K, Zwetyenga N and Khan NA: Peroxisome
proliferator-activated receptor alpha deficiency impairs regulatory
T cell functions: Possible application in the inhibition of
melanoma tumor growth in mice. Biochimie. 131:1–10. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Berod L, Friedrich C, Nandan A, Freitag J,
Hagemann S, Harmrolfs K, Sandouk A, Hesse C, Castro CN, Bähre H, et
al: De novo fatty acid synthesis controls the fate between
regulatory T and T helper 17 cells. Nat Med. 20:1327–1333. 2014.
View Article : Google Scholar : PubMed/NCBI
|
